• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.血管靶向光动力疗法对前列腺癌的局部治疗
ScientificWorldJournal. 2008 Oct 3;8:963-73. doi: 10.1100/tsw.2008.127.
2
Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.美国进行的一项针对单侧低危前列腺癌患者前列腺半切除的 WST11 血管靶向光动力疗法的 I/II 期多中心试验的最终结果。
J Urol. 2016 Oct;196(4):1096-104. doi: 10.1016/j.juro.2016.05.113. Epub 2016 Jun 9.
3
Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials).局部前列腺癌的血管靶向光动力疗法的中期随访:使用 TOOKAD 可溶性 WST-11(II 期试验)。
Eur Urol Focus. 2019 Nov;5(6):1022-1028. doi: 10.1016/j.euf.2018.04.003. Epub 2018 Apr 13.
4
Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy-A review.使用WST-09和WST-11介导的血管靶向光动力疗法治疗局限性前列腺癌——综述
Photodiagnosis Photodyn Ther. 2015 Dec;12(4):567-74. doi: 10.1016/j.pdpdt.2015.10.001. Epub 2015 Oct 20.
5
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.帕利泊芬血管靶向光动力疗法与主动监测治疗低危前列腺癌男性患者(CLIN1001 PCM301):一项开放标签、3 期、随机对照临床试验。
Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. Epub 2016 Dec 20.
6
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.局限性前列腺癌的聚焦治疗:对理论依据和治疗方式的批判性评估
J Urol. 2007 Dec;178(6):2260-7. doi: 10.1016/j.juro.2007.08.072. Epub 2007 Oct 15.
7
Evaluating localized prostate cancer and identifying candidates for focal therapy.评估局限性前列腺癌并确定聚焦治疗的候选者。
Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004.
8
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy.使用WST11-血管靶向光动力(VTP)疗法确定实现局限性前列腺癌微创聚焦消融的最佳药物剂量和光剂量指数。
BJU Int. 2015 Dec;116(6):888-96. doi: 10.1111/bju.12816. Epub 2015 Apr 21.
9
[Focal Laser Ablation and Photodynamic Vascular Therapy with soluble TOOKAD® in the treatment of low risk prostate cancer].[聚焦激光消融与可溶性TOOKAD®光动力血管治疗用于低危前列腺癌的治疗]
Arch Esp Urol. 2016 Jul;69(6):327-36.
10
Vascular Targeted Photodynamic Therapy with Padeliporfin for Low Risk Prostate Cancer Treatment: Midterm Oncologic Outcomes.血管靶向光动力疗法联合 padeliporfin 治疗低危前列腺癌:中期肿瘤学结果。
J Urol. 2017 Aug;198(2):335-344. doi: 10.1016/j.juro.2017.03.119. Epub 2017 Mar 18.

引用本文的文献

1
An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.经组织病理学检查和磁共振成像分析光动力学疗法对前列腺癌组织的影响。
Int J Mol Sci. 2022 Sep 26;23(19):11354. doi: 10.3390/ijms231911354.
2
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges.新兴的光动力/声动力疗法治疗泌尿系统癌症:进展与挑战。
J Nanobiotechnology. 2022 Oct 4;20(1):437. doi: 10.1186/s12951-022-01637-w.
3
Photodynamic Therapy and the Biophysics of the Tumor Microenvironment.光动力疗法与肿瘤微环境的生物物理
Photochem Photobiol. 2020 Mar;96(2):232-259. doi: 10.1111/php.13209. Epub 2020 Mar 5.
4
A Surgical View of Photodynamic Therapy in Oncology: A Review.肿瘤学中光动力疗法的外科视角综述
Surg J (N Y). 2015 Oct 15;1(1):e1-e15. doi: 10.1055/s-0035-1565246. eCollection 2015 Dec.
5
Photosensitizers in prostate cancer therapy.前列腺癌治疗中的光敏剂。
Oncotarget. 2017 May 2;8(18):30524-30538. doi: 10.18632/oncotarget.15496.
6
Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.使用卟吩姆钠和帕德立卟吩作为局部前列腺癌局部治疗方法的血管靶向光化学疗法——临床医生的见解
World J Methodol. 2016 Mar 26;6(1):65-76. doi: 10.5662/wjm.v6.i1.65.
7
Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.用于光动力疗法的稳定合成细菌叶绿素:二氰基外围基团、中心金属取代(2H、Zn、Pd)和 Cremophor EL 递送的作用。
ChemMedChem. 2012 Dec;7(12):2155-67. doi: 10.1002/cmdc.201200351. Epub 2012 Oct 12.
8
Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors.新型设计原则使成像和治疗剂能够特异性靶向乳腺肿瘤的坏死区域。
Breast Cancer Res. 2010;12(3):R29. doi: 10.1186/bcr2579. Epub 2010 May 24.
9
Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad.Tookad 介导的血管靶向光动力疗法(VTP)使实体瘤内的营养动脉和引流静脉永久性闭塞。
PLoS One. 2010 Apr 22;5(4):e10282. doi: 10.1371/journal.pone.0010282.
10
Focal therapy: a new paradigm for the treatment of prostate cancer.聚焦治疗:前列腺癌治疗的新范式。
Rev Urol. 2009 Fall;11(4):203-12.

本文引用的文献

1
The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.托卡德介导的前列腺光动力消融对邻近组织的影响——犬模型体内研究
Photochem Photobiol Sci. 2007 Dec;6(12):1318-24. doi: 10.1039/b705984a. Epub 2007 Aug 22.
2
Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.以治愈为目的的前列腺癌观察等待管理:约翰霍普金斯医院经验的更新
J Urol. 2007 Dec;178(6):2359-64; discussion 2364-5. doi: 10.1016/j.juro.2007.08.039. Epub 2007 Oct 22.
3
Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.用于预测惰性前列腺癌的列线图:对筛查发现人群的影响。
Cancer. 2007 Nov 15;110(10):2218-21. doi: 10.1002/cncr.23029.
4
Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.采用钯-细菌脱镁叶绿酸光敏剂的血管靶向光动力疗法治疗根治性放疗后复发性前列腺癌:安全性及治疗反应评估
J Urol. 2007 Nov;178(5):1974-9; discussion 1979. doi: 10.1016/j.juro.2007.07.036. Epub 2007 Sep 17.
5
Tumor vascular area correlates with photosensitizer uptake: analysis of verteporfin microvascular delivery in the Dunning rat prostate tumor.肿瘤血管面积与光敏剂摄取相关:对丹宁大鼠前列腺肿瘤中维替泊芬微血管递送的分析
Photochem Photobiol. 2006 Sep-Oct;82(5):1348-57. doi: 10.1562/2006-03-25-ra-858.
6
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
7
Re-biopsy of the prostate using a stereotactic transperineal technique.使用立体定向经会阴技术对前列腺进行再次活检。
J Urol. 2006 Oct;176(4 Pt 1):1376-81; discussion 1381. doi: 10.1016/j.juro.2006.06.030.
8
Pretreatment photosensitizer dosimetry reduces variation in tumor response.预处理光敏剂剂量测定可减少肿瘤反应的差异。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1211-20. doi: 10.1016/j.ijrobp.2005.11.019.
9
Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.血管靶向光致敏作用导致的肿瘤血管通透性:效应、机制及治疗意义
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):917-23. doi: 10.1158/1078-0432.CCR-05-1673.
10
Role of prostate biopsy schemes in accurate prediction of Gleason scores.前列腺活检方案在准确预测 Gleason 评分中的作用。
Urology. 2006 Feb;67(2):379-83. doi: 10.1016/j.urology.2005.08.018.

血管靶向光动力疗法对前列腺癌的局部治疗

Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.

作者信息

Eggener Scott E, Coleman Jonathan A

机构信息

Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA.

出版信息

ScientificWorldJournal. 2008 Oct 3;8:963-73. doi: 10.1100/tsw.2008.127.

DOI:10.1100/tsw.2008.127
PMID:18836668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2692990/
Abstract

Epidemiologic and pathologic features of prostate cancer have given rise to an interest in focal treatment for carefully selected patients. Prostate cancer remains highly prevalent, particularly in the United States and Europe. As screening programs have become more aggressive and widespread, a substantial proportion of men diagnosed with localized prostate cancer have disease characteristics associated with a low risk of progression. Treatments such as radical prostatectomy and radiation therapy can lead to durable recurrence-free survival in most patients but carry variable risks of bowel, urinary, and sexual side effects. Few men and few urologists are comfortable leaving a potentially curable prostate cancer untreated. Focal therapy offers an attractive alternative to the patient faced with a choice between aggressive local intervention (radiation or surgery) and watchful waiting. Contemporary diagnostic biopsy strategies and imaging tools and the development of predictive statistical models (nomograms) have led to improvements in tumor characterization and risk-stratification, making focal therapy a viable treatment option for specific men. This article reviews the rationale and indications for focal therapy and highlights vascular-targeted photodynamic therapy (PDT) as one of many promising focal therapy techniques.

摘要

前列腺癌的流行病学和病理特征引发了人们对为精心挑选的患者进行局部治疗的兴趣。前列腺癌仍然非常普遍,尤其是在美国和欧洲。随着筛查计划变得更加积极和广泛,相当一部分被诊断为局限性前列腺癌的男性具有与低进展风险相关的疾病特征。根治性前列腺切除术和放射治疗等治疗方法可以使大多数患者实现持久的无复发生存,但会带来不同程度的肠道、泌尿和性功能方面的副作用风险。很少有男性和泌尿外科医生愿意对潜在可治愈的前列腺癌不进行治疗。对于面临积极局部干预(放疗或手术)和密切观察等待之间选择的患者,局部治疗提供了一个有吸引力的替代方案。当代诊断性活检策略和成像工具以及预测性统计模型(列线图)的发展,已使肿瘤特征描述和风险分层得到改善,使局部治疗成为特定男性可行的治疗选择。本文回顾了局部治疗的基本原理和适应症,并重点介绍了血管靶向光动力疗法(PDT),它是众多有前景的局部治疗技术之一。